Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $1,600,269 (100.0% shares, 0.0% debt)

Holdings (36)

MERUS N V 10.5%
Value ($000) $167,366 Shares 3,350,000 Est. Cost $25.91 Unrealized
VERA VERA THERAPEUTICS INC 6.8%
Value ($000) $109,395 Shares 2,475,000 Est. Cost $8.35 Unrealized +354.4%
XENE XENON PHARMACEUTICALS INC 6.6%
Value ($000) $106,299 Shares 2,700,000 Est. Cost $30.11 Unrealized +33.9%
PCVX VAXCYTE INC 6.6%
Value ($000) $105,128 Shares 920,000 Est. Cost $53.62 Unrealized +68.1%
ELVN ENLIVEN THERAPEUTICS INC 6.5%
Value ($000) $104,714 Shares 4,100,000 Est. Cost $18.63 Unrealized +24.3%
NUVL NUVALENT INC 6.0%
Value ($000) $96,162 Shares 940,000 Est. Cost $45.30 Unrealized +83.1%
COGT COGENT BIOSCIENCES INC 5.1%
Value ($000) $81,431 Shares 7,539,930 Est. Cost $8.23 Unrealized +18.3%
ALKS ALKERMES PLC 5.1%
Value ($000) $81,171 Shares 2,900,000 Est. Cost $25.65 Unrealized +3.9%
SLNO SOLENO THERAPEUTICS INC 4.0%
Value ($000) $63,617 Shares 1,260,000 Est. Cost $38.06 Unrealized +25.8%
SYRE SPYRE THERAPEUTICS INC 3.7%
Value ($000) $58,470 Shares 1,988,084 Est. Cost $14.79 Unrealized +88.3%
VRDN VIRIDIAN THERAPEUTICS INC 3.6%
Value ($000) $58,015 Shares 2,550,124 Est. Cost $16.71 Unrealized -2.2%
CLDX CELLDEX THERAPEUTICS INC NEW 3.4%
Value ($000) $55,028 Shares 1,618,937 Est. Cost $35.24 Unrealized +8.1%
MIND MEDICINE MINDMED INC 2.8%
Value ($000) $45,520 Shares 8,000,000 Est. Cost $8.64 Unrealized
CATX PERSPECTIVE THERAPEUTICS INC 2.8%
Value ($000) $44,723 Shares 3,350,000 Est. Cost $14.46 Unrealized -8.0%
NRIX NURIX THERAPEUTICS INC 2.3%
Value ($000) $37,076 Shares 1,650,000 Est. Cost $22.65 Unrealized 0.0%
PHVS PHARVARIS N V 2.2%
Value ($000) $35,400 Shares 1,911,433 Est. Cost $23.20 Unrealized -21.2%
KURA KURA ONCOLOGY INC 2.2%
Value ($000) $35,172 Shares 1,800,000 Est. Cost $15.75 Unrealized +28.7%
RYTM RHYTHM PHARMACEUTICALS INC 2.1%
Value ($000) $34,054 Shares 650,000 Est. Cost $24.90 Unrealized +92.5%
ORKA ORUKA THERAPEUTICS INC 2.1%
Value ($000) $33,572 Shares 1,369,714 Est. Cost $34.79 Unrealized 0.0%
ARVN ARVINAS INC 1.8%
Value ($000) $29,556 Shares 1,200,000 Est. Cost $29.08 Unrealized -10.2%
CELC CELCUITY INC 1.4%
Value ($000) $22,698 Shares 1,522,332 Est. Cost $18.21 Unrealized -9.5%
CNTA CENTESSA PHARMACEUTICALS PLC 1.3%
Value ($000) $21,587 Shares 1,350,000 Est. Cost $15.99 Unrealized
NKTX NKARTA INC 1.3%
Value ($000) $21,073 Shares 4,662,073 Est. Cost $4.61 Unrealized +23.3%
ORIC ORIC PHARMACEUTICALS INC 1.3%
Value ($000) $20,500 Shares 2,000,000 Est. Cost $11.88 Unrealized -16.7%
CCCC C4 THERAPEUTICS INC 1.2%
Value ($000) $19,439 Shares 3,410,384 Est. Cost $2.28 Unrealized +163.9%
THIRD HARMONIC BIO INC 1.2%
Value ($000) $18,436 Shares 1,360,569 Est. Cost $12.09 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 1.1%
Value ($000) $17,036 Shares 885,000 Est. Cost $21.40 Unrealized -3.5%
APGE APOGEE THERAPEUTICS INC 1.1%
Value ($000) $17,035 Shares 290,000 Est. Cost $25.01 Unrealized +91.5%
ABVX ABIVAX SA 0.9%
Value ($000) $14,793 Shares 1,284,110 Est. Cost $10.70 Unrealized
TIL INSTIL BIO INC 0.6%
Value ($000) $10,161 Shares 150,929 Est. Cost $23.54 Unrealized 0.0%
NGNE NEUROGENE INC 0.5%
Value ($000) $8,392 Shares 200,000 Est. Cost $33.40 Unrealized +16.1%
PCSC PERCEPTIVE CAP SOLUTIONS COR 0.5%
Value ($000) $7,508 Shares 750,000 Est. Cost $10.07 Unrealized -0.1%
BBOT HELIX ACQUISITION CORP II 0.3%
Value ($000) $5,225 Shares 500,000 Est. Cost $10.35 Unrealized +0.1%
CABA CABALETTA BIO INC 0.3%
Value ($000) $5,192 Shares 1,100,000 Est. Cost $7.66 Unrealized -24.4%
VTGN VISTAGEN THERAPEUTICS INC 0.3%
Value ($000) $4,741 Shares 1,575,000 Est. Cost $4.44 Unrealized -23.1%
AVTX AVALO THERAPEUTICS INC 0.3%
Value ($000) $4,589 Shares 483,000 Est. Cost $10.53 Unrealized -2.1%